Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Tracking and Quantification of Magnetically Labeled Stem Cells using Magnetic Resonance Imaging.

Goodfellow F, Simchick GA, Mortensen LJ, Stice SL, Zhao Q.

Adv Funct Mater. 2016 Jun 14;26(22):3899-3915. doi: 10.1002/adfm.201504444. Epub 2016 Feb 17.

2.

The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis.

Sechler M, Parrish JK, Birks DK, Jedlicka P.

Oncogene. 2017 Jul 20;36(29):4150-4160. doi: 10.1038/onc.2017.44. Epub 2017 Mar 20.

PMID:
28319067
3.

Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.

Jin L, Chun J, Pan C, Alesi GN, Li D, Magliocca KR, Kang Y, Chen ZG, Shin DM, Khuri FR, Fan J, Kang S.

Oncogene. 2017 Jul 6;36(27):3797-3806. doi: 10.1038/onc.2017.6. Epub 2017 Feb 20.

4.

Multimodality Imaging of Bone Marrow-Derived Dendritic Cell Migration and Antitumor Immunity.

Ahn SB, Lee SB, Singh TD, Cho SJ, Kim SK, Lee IK, Jeong SY, Ahn BC, Lee J, Lee SW, Jeon YH.

Transl Oncol. 2017 Apr;10(2):262-270. doi: 10.1016/j.tranon.2017.01.003. Epub 2017 Feb 16.

5.

Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach.

Cho IK, Wang S, Mao H, Chan AW.

Am J Nucl Med Mol Imaging. 2016 Sep 22;6(5):234-261. eCollection 2016. Review.

6.

Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells.

Lee HW, Gangadaran P, Kalimuthu S, Ahn BC.

Biomed Res Int. 2016;2016:1946585. Epub 2016 Sep 20. Review.

7.

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.

Quail DF, Bowman RL, Akkari L, Quick ML, Schuhmacher AJ, Huse JT, Holland EC, Sutton JC, Joyce JA.

Science. 2016 May 20;352(6288):aad3018. doi: 10.1126/science.aad3018.

8.

Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness.

Nguyen A, Yoshida M, Goodarzi H, Tavazoie SF.

Nat Commun. 2016 May 3;7:11246. doi: 10.1038/ncomms11246.

9.

Bcl-xL promotes metastasis independent of its anti-apoptotic activity.

Choi S, Chen Z, Tang LH, Fang Y, Shin SJ, Panarelli NC, Chen YT, Li Y, Jiang X, Du YC.

Nat Commun. 2016 Jan 20;7:10384. doi: 10.1038/ncomms10384.

10.

Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.

Wiesner T, Lee W, Obenauf AC, Ran L, Murali R, Zhang QF, Wong EW, Hu W, Scott SN, Shah RH, Landa I, Button J, Lailler N, Sboner A, Gao D, Murphy DA, Cao Z, Shukla S, Hollmann TJ, Wang L, Borsu L, Merghoub T, Schwartz GK, Postow MA, Ariyan CE, Fagin JA, Zheng D, Ladanyi M, Busam KJ, Berger MF, Chen Y, Chi P.

Nature. 2015 Oct 15;526(7573):453-7. doi: 10.1038/nature15258. Epub 2015 Oct 7.

11.

Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model.

Yang FY, Chang WY, Lin WT, Hwang JJ, Chien YC, Wang HE, Tsai ML.

Oncotarget. 2015 Nov 3;6(34):36260-8. doi: 10.18632/oncotarget.5389.

12.

Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.

Schaub FX, Reza MS, Flaveny CA, Li W, Musicant AM, Hoxha S, Guo M, Cleveland JL, Amelio AL.

Cancer Res. 2015 Dec 1;75(23):5023-33. doi: 10.1158/0008-5472.CAN-14-3538. Epub 2015 Sep 30.

13.

Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype.

Bleau AM, Zandueta C, Redrado M, Martínez-Canarias S, Larzábal L, Montuenga LM, Calvo A, Lecanda F.

Oncotarget. 2015 Sep 29;6(29):27288-303. doi: 10.18632/oncotarget.4803.

14.

Recent Advances in Higher-Order, Multimodal, Biomedical Imaging Agents.

Rieffel J, Chitgupi U, Lovell JF.

Small. 2015 Sep 16;11(35):4445-61. doi: 10.1002/smll.201500735. Epub 2015 Jul 16. Review.

15.

Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer.

Ross JB, Huh D, Noble LB, Tavazoie SF.

Nat Cell Biol. 2015 May;17(5):651-64. doi: 10.1038/ncb3148. Epub 2015 Apr 13.

16.

Molecular imaging of apoptosis: from micro to macro.

Zeng W, Wang X, Xu P, Liu G, Eden HS, Chen X.

Theranostics. 2015 Feb 20;5(6):559-82. doi: 10.7150/thno.11548. eCollection 2015. Review.

17.

Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.

McCarroll JA, Dwarte T, Baigude H, Dang J, Yang L, Erlich RB, Kimpton K, Teo J, Sagnella SM, Akerfeldt MC, Liu J, Phillips PA, Rana TM, Kavallaris M.

Oncotarget. 2015 May 20;6(14):12020-34.

18.

Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S.

Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, Brogi E, Brastianos PK, Hahn WC, Holsinger LJ, Massagué J, Leslie CS, Joyce JA.

Nat Cell Biol. 2014 Sep;16(9):876-88. doi: 10.1038/ncb3011. Epub 2014 Aug 3.

19.

A novel luciferase fusion protein for highly sensitive optical imaging: from single-cell analysis to in vivo whole-body bioluminescence imaging.

Mezzanotte L, Blankevoort V, Löwik CW, Kaijzel EL.

Anal Bioanal Chem. 2014 Sep;406(23):5727-34. doi: 10.1007/s00216-014-7917-2. Epub 2014 Jun 24.

20.

Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex.

Cheal SM, Xu H, Guo HF, Zanzonico PB, Larson SM, Cheung NK.

Mol Cancer Ther. 2014 Jul;13(7):1803-12. doi: 10.1158/1535-7163.MCT-13-0933. Epub 2014 Jun 18.

Supplemental Content

Support Center